211 related articles for article (PubMed ID: 37976363)
1. Increased palmitoylation improves estrogen receptor alpha-dependent hippocampal synaptic deficits in a mouse model of synucleinopathy.
Moors TE; Li S; McCaffery TD; Ho GPH; Bechade PA; Pham LN; Ericsson M; Nuber S
Sci Adv; 2023 Nov; 9(46):eadj1454. PubMed ID: 37976363
[TBL] [Abstract][Full Text] [Related]
2. Female Sex and Brain-Selective Estrogen Benefit α-Synuclein Tetramerization and the PD-like Motor Syndrome in 3K Transgenic Mice.
Rajsombath MM; Nam AY; Ericsson M; Nuber S
J Neurosci; 2019 Sep; 39(38):7628-7640. PubMed ID: 31405930
[TBL] [Abstract][Full Text] [Related]
3. Tau is required for progressive synaptic and memory deficits in a transgenic mouse model of α-synucleinopathy.
Singh B; Covelo A; Martell-Martínez H; Nanclares C; Sherman MA; Okematti E; Meints J; Teravskis PJ; Gallardo C; Savonenko AV; Benneyworth MA; Lesné SE; Liao D; Araque A; Lee MK
Acta Neuropathol; 2019 Oct; 138(4):551-574. PubMed ID: 31168644
[TBL] [Abstract][Full Text] [Related]
4. Loss of tau expression attenuates neurodegeneration associated with α-synucleinopathy.
Vermilyea SC; Christensen A; Meints J; Singh B; Martell-Martínez H; Karim MR; Lee MK
Transl Neurodegener; 2022 Jul; 11(1):34. PubMed ID: 35773715
[TBL] [Abstract][Full Text] [Related]
5. A Stearoyl-Coenzyme A Desaturase Inhibitor Prevents Multiple Parkinson Disease Phenotypes in α-Synuclein Mice.
Nuber S; Nam AY; Rajsombath MM; Cirka H; Hronowski X; Wang J; Hodgetts K; Kalinichenko LS; Müller CP; Lambrecht V; Winkler J; Weihofen A; Imberdis T; Dettmer U; Fanning S; Selkoe DJ
Ann Neurol; 2021 Jan; 89(1):74-90. PubMed ID: 32996158
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of Cellular Palmitoylation Mitigates α-Synuclein Accumulation and Neurotoxicity.
Ho GPH; Ramalingam N; Imberdis T; Wilkie EC; Dettmer U; Selkoe DJ
Mov Disord; 2021 Feb; 36(2):348-359. PubMed ID: 33103814
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the in vivo induction and transmission of α-synuclein pathology by mutant α-synuclein fibril seeds in transgenic mice.
Rutherford NJ; Dhillon JS; Riffe CJ; Howard JK; Brooks M; Giasson BI
Hum Mol Genet; 2017 Dec; 26(24):4906-4915. PubMed ID: 29036344
[TBL] [Abstract][Full Text] [Related]
8. Prominent microglial inclusions in transgenic mouse models of α-synucleinopathy that are distinct from neuronal lesions.
Tanriöver G; Bacioglu M; Schweighauser M; Mahler J; Wegenast-Braun BM; Skodras A; Obermüller U; Barth M; Kronenberg-Versteeg D; Nilsson KPR; Shimshek DR; Kahle PJ; Eisele YS; Jucker M
Acta Neuropathol Commun; 2020 Aug; 8(1):133. PubMed ID: 32787922
[TBL] [Abstract][Full Text] [Related]
9. Memory-Related Synaptic Plasticity Is Sexually Dimorphic in Rodent Hippocampus.
Wang W; Le AA; Hou B; Lauterborn JC; Cox CD; Levin ER; Lynch G; Gall CM
J Neurosci; 2018 Sep; 38(37):7935-7951. PubMed ID: 30209204
[TBL] [Abstract][Full Text] [Related]
10. Cell models of lipid-rich α-synuclein aggregation validate known modifiers of α-synuclein biology and identify stearoyl-CoA desaturase.
Imberdis T; Negri J; Ramalingam N; Terry-Kantor E; Ho GPH; Fanning S; Stirtz G; Kim TE; Levy OA; Young-Pearse TL; Selkoe D; Dettmer U
Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20760-20769. PubMed ID: 31548371
[TBL] [Abstract][Full Text] [Related]
11. Wild-type GBA1 increases the α-synuclein tetramer-monomer ratio, reduces lipid-rich aggregates, and attenuates motor and cognitive deficits in mice.
Glajch KE; Moors TE; Chen Y; Bechade PA; Nam AY; Rajsombath MM; McCaffery TD; Dettmer U; Weihofen A; Hirst WD; Selkoe DJ; Nuber S
Proc Natl Acad Sci U S A; 2021 Aug; 118(31):. PubMed ID: 34326260
[TBL] [Abstract][Full Text] [Related]
12. Endoplasmic reticulum stress is important for the manifestations of α-synucleinopathy in vivo.
Colla E; Coune P; Liu Y; Pletnikova O; Troncoso JC; Iwatsubo T; Schneider BL; Lee MK
J Neurosci; 2012 Mar; 32(10):3306-20. PubMed ID: 22399753
[TBL] [Abstract][Full Text] [Related]
13. Pathogenic Mechanisms of Cytosolic and Membrane-Enriched α-Synuclein Converge on Fatty Acid Homeostasis.
Tripathi A; Alnakhala H; Terry-Kantor E; Newman A; Liu L; Imberdis T; Fanning S; Nuber S; Ramalingam N; Selkoe D; Dettmer U
J Neurosci; 2022 Mar; 42(10):2116-2130. PubMed ID: 35086904
[TBL] [Abstract][Full Text] [Related]
14. Accumulation of toxic α-synuclein oligomer within endoplasmic reticulum occurs in α-synucleinopathy in vivo.
Colla E; Jensen PH; Pletnikova O; Troncoso JC; Glabe C; Lee MK
J Neurosci; 2012 Mar; 32(10):3301-5. PubMed ID: 22399752
[TBL] [Abstract][Full Text] [Related]
15. Changes in Drp1 Function and Mitochondrial Morphology Are Associated with the α-Synuclein Pathology in a Transgenic Mouse Model of Parkinson's Disease.
Portz P; Lee MK
Cells; 2021 Apr; 10(4):. PubMed ID: 33924585
[TBL] [Abstract][Full Text] [Related]
16. Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons.
Colla E; Panattoni G; Ricci A; Rizzi C; Rota L; Carucci N; Valvano V; Gobbo F; Capsoni S; Lee MK; Cattaneo A
Neurobiol Dis; 2018 Mar; 111():36-47. PubMed ID: 29246724
[TBL] [Abstract][Full Text] [Related]
17. A53T Mutant Alpha-Synuclein Induces Tau-Dependent Postsynaptic Impairment Independently of Neurodegenerative Changes.
Teravskis PJ; Covelo A; Miller EC; Singh B; Martell-Martínez HA; Benneyworth MA; Gallardo C; Oxnard BR; Araque A; Lee MK; Liao D
J Neurosci; 2018 Nov; 38(45):9754-9767. PubMed ID: 30249789
[TBL] [Abstract][Full Text] [Related]
18. Re-Opening the Critical Window for Estrogen Therapy.
Bean LA; Kumar A; Rani A; Guidi M; Rosario AM; Cruz PE; Golde TE; Foster TC
J Neurosci; 2015 Dec; 35(49):16077-93. PubMed ID: 26658861
[TBL] [Abstract][Full Text] [Related]
19. Comparative analyses of the in vivo induction and transmission of α-synuclein pathology in transgenic mice by MSA brain lysate and recombinant α-synuclein fibrils.
Dhillon JS; Trejo-Lopez JA; Riffe C; Levites Y; Sacino AN; Borchelt DR; Yachnis AY; Giasson BI
Acta Neuropathol Commun; 2019 May; 7(1):80. PubMed ID: 31109378
[TBL] [Abstract][Full Text] [Related]
20. Behavioral characterization of A53T mice reveals early and late stage deficits related to Parkinson's disease.
Paumier KL; Sukoff Rizzo SJ; Berger Z; Chen Y; Gonzales C; Kaftan E; Li L; Lotarski S; Monaghan M; Shen W; Stolyar P; Vasilyev D; Zaleska M; D Hirst W; Dunlop J
PLoS One; 2013; 8(8):e70274. PubMed ID: 23936403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
